Outline

Legal Authorization of Medical Institutions - Advanced Medical Care B

Advanced Medical Care B (As of April 1,2023)

Name of Advanced Medical Technologies Clinical Departments Date of Approval
Combined therapy of subcutaneous administration of interferon alpha and oral administration of zidovudine: adult T cell leukemia lymphoma (limited to symptomatic smoldering leukemia or chronic leukemia that lacks factors for poor prognosis) Hematology June 1, 2015
Dose-dense temozolomide therapy: glioblastoma (limited to recurrence or worsening after primary care at onset) Neurosurgery September 1, 2017
Combined postoperative therapy of internal administration of capecitabine and intravenous administration of oxaliplatin
Small bowel adenocarcinoma (limited to Stage I, II, or III cases determined to have been completely removed via visual inspection and pathological findings)		 Gastroenterological Surgery April 1, 2018
Liver transplant surgery Unresectable hilar bile duct cancer Pediatric Surgery, Transplantation September 1, 2022
Repetitive transcranial magnetic stimulation Depression (only for patients in acute phase and only if there is resistance against pharmaceutical treatments) Neuropsychiatry January 1, 2023
Outline